共 10 条
[1]
CALIMLIM LR, 1971, EUR J CLIN INVEST, V1, P313
[2]
EFFECT OF ANTACID ADMINISTRATION ON ABSORPTION AND METABOLISM OF LEVODOPA
[J].
JOURNAL OF CLINICAL PHARMACOLOGY AND NEW DRUGS,
1972, 12 (07)
:263-&
LEON, AS
;
SPIEGEL, HE
.
[3]
MATHWES DM, 1965, GUT, V6, P411
[4]
METOCLOPRAMIDE, GASTRIC-EMPTYING AND L-DOPA ABSORPTION
[J].
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE,
1974, 4 (02)
:144-148
MEARRICK, PT
;
WADE, DN
;
BIRKETT, DJ
;
MORRIS, J
.
[5]
DOSAGE FORM DESIGN FOR IMPROVEMENT OF BIOAVAILABILITY OF LEVODOPA .3. INFLUENCE OF DOSE ON PHARMACOKINETIC BEHAVIOR OF LEVODOPA IN DOGS AND PARKINSONIAN-PATIENTS
[J].
JOURNAL OF PHARMACEUTICAL SCIENCES,
1980, 69 (12)
:1374-1378
SASAHARA, K
;
NITANAI, T
;
HABARA, T
;
MORIOKA, T
;
NAKAJIMA, E
.
[6]
DOSAGE FORM DESIGN FOR IMPROVEMENT OF BIOAVAILABILITY OF LEVODOPA .2. BIOAVAILABILITY OF MARKETED LEVODOPA PREPARATIONS IN DOGS AND PARKINSONIAN-PATIENTS
[J].
JOURNAL OF PHARMACEUTICAL SCIENCES,
1980, 69 (03)
:261-265
SASAHARA, K
;
NITANAI, T
;
HABARA, T
;
MORIOKA, T
;
NAKAJIMA, E
.
[7]
SASAHARA K, 1978, Annual Report of Sankyo Research Laboratories, V30, P65
[8]
DOSAGE FORM DESIGN FOR IMPROVEMENT OF BIOAVAILABILITY OF LEVODOPA-IV - POSSIBLE CAUSES OF LOW BIOAVAILABILITY OF ORAL LEVODOPA IN DOGS
[J].
JOURNAL OF PHARMACEUTICAL SCIENCES,
1981, 70 (07)
:730-733
SASAHARA, K
;
NITANAI, T
;
HABARA, T
;
KOJIMA, T
;
KAWAHARA, Y
;
MORIOKA, T
;
NAKAJIMA, E
.
[9]
SPENCER RP, 1969, AM J CLIN NUTR, V22, P292
[10]
VARIABILITY OF L-DOPA ABSORPTION IN MAN
[J].
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE,
1974, 4 (02)
:138-143
WADE, DN
;
MEARRICK, PT
;
BIRKETT, DJ
;
MORRIS, J
.